Medscape Medical News, August 14, 2009 FDA Approves Extended-Release Lamotrigine for Treatment of Epilepsy The FDA has approved Lamictal as once-daily adjunctive therapy for partial-onset seizures ...

Early and targeted therapy in the setting of a specialty center provides the optimal approach for slowing the pace of cognitive impairment in children with epilepsy. Among the one-third of adults ...

While generalized seizures cause convulsions, epilepsy includes other types like absence seizures (brief awareness lapses), ...

For decades, the Epilepsy Foundation has supported the epilepsy community. Your empowered journey begins here with education, research, & more.

Despite an array of new antiepileptic medications introduced over the past 3 decades, long-term outcomes for patients with newly diagnosed epilepsy are largely unchanged. Why? Patients with ...

Figure 1 depicts a model for epilepsy care in resource-poor countries from the community to the national level, taking into consideration the heterogeneity of epileptic disorders and a need-based ...

These factors make it critical to advocate for and share resources with people managing epilepsy, so they can educate and ...

The founder of Dream Rich and Arte de la Moda, Mumphord has spent a decade promoting Detroit’s fashion scene, empowering ...

Mark Purple Day 2025 by learning more about epilepsy and how to raise awareness. Expert insights reveal treatment options and ...

The diagnosis of epilepsy is fundamentally a clinical judgment made on the basis of a clinical history. The accuracy of the diagnosis depends on the skill and experience of the physician and the ...